Clinical efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria at the China-Myanmar Border

Ying Wang, Zhaoqing Yang, Lili Yuan, Guofa Zhou, Daniel Parker, Ming Chieh Lee, Guiyun Yan, Qi Fan, Yuping Xiao, Yaming Cao, Liwang Cui

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Artemisinin-based combination therapies (ACTs) are currently used as the first-line therapy for uncomplicated Plasmodium falciparum malaria. However, the recent emergence and/or spread of artemisinin resistance in parts of Greater Mekong Subregion (GMS) of southeast Asia requires close monitoring of the therapeutic efficacy of ACTs. This study was conducted from March 2012 to December 2013 in four clinics and seven villages along the China-Myanmar border. A total of 109 patients with uncomplicated falciparum malaria were treated with dihydroartemisinin-piperaquine (DP) and followed up on days 1, 2, 3, 7, 14, 21, 28, and 42 after treatment. A total of 71 patients (22 children and 49 adults) completed the 42-day follow-up. DP remained highly efficacious for treatment of uncomplicated falciparum malaria with an overall 42-day cure rate of 100%. The day 3 parasite-positive rate was 7.04% (5/71).Within 14 days of treatment, a total of 13 (18.31%) patients had detectable gametocytes and a large proportion of these were persistent from the first three days of treatment. The presence of gametocytes in patients through 14 days after DP treatment suggests that the incorporation of a single dose of primaquine for clearing gametocytemia should be considered for blocking parasite transmission.

Original languageEnglish (US)
Pages (from-to)577-583
Number of pages7
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume93
Issue number3
DOIs
StatePublished - Sep 1 2015

Fingerprint

dihydroartemisinin
Myanmar
Falciparum Malaria
China
Therapeutics
Parasites
Primaquine
piperaquine
Southeastern Asia

All Science Journal Classification (ASJC) codes

  • Parasitology
  • Infectious Diseases
  • Virology

Cite this

Wang, Ying ; Yang, Zhaoqing ; Yuan, Lili ; Zhou, Guofa ; Parker, Daniel ; Lee, Ming Chieh ; Yan, Guiyun ; Fan, Qi ; Xiao, Yuping ; Cao, Yaming ; Cui, Liwang. / Clinical efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria at the China-Myanmar Border. In: American Journal of Tropical Medicine and Hygiene. 2015 ; Vol. 93, No. 3. pp. 577-583.
@article{645b7dec658a4c369bbac86905b60eba,
title = "Clinical efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria at the China-Myanmar Border",
abstract = "Artemisinin-based combination therapies (ACTs) are currently used as the first-line therapy for uncomplicated Plasmodium falciparum malaria. However, the recent emergence and/or spread of artemisinin resistance in parts of Greater Mekong Subregion (GMS) of southeast Asia requires close monitoring of the therapeutic efficacy of ACTs. This study was conducted from March 2012 to December 2013 in four clinics and seven villages along the China-Myanmar border. A total of 109 patients with uncomplicated falciparum malaria were treated with dihydroartemisinin-piperaquine (DP) and followed up on days 1, 2, 3, 7, 14, 21, 28, and 42 after treatment. A total of 71 patients (22 children and 49 adults) completed the 42-day follow-up. DP remained highly efficacious for treatment of uncomplicated falciparum malaria with an overall 42-day cure rate of 100{\%}. The day 3 parasite-positive rate was 7.04{\%} (5/71).Within 14 days of treatment, a total of 13 (18.31{\%}) patients had detectable gametocytes and a large proportion of these were persistent from the first three days of treatment. The presence of gametocytes in patients through 14 days after DP treatment suggests that the incorporation of a single dose of primaquine for clearing gametocytemia should be considered for blocking parasite transmission.",
author = "Ying Wang and Zhaoqing Yang and Lili Yuan and Guofa Zhou and Daniel Parker and Lee, {Ming Chieh} and Guiyun Yan and Qi Fan and Yuping Xiao and Yaming Cao and Liwang Cui",
year = "2015",
month = "9",
day = "1",
doi = "10.4269/ajtmh.15-0029",
language = "English (US)",
volume = "93",
pages = "577--583",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "3",

}

Clinical efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria at the China-Myanmar Border. / Wang, Ying; Yang, Zhaoqing; Yuan, Lili; Zhou, Guofa; Parker, Daniel; Lee, Ming Chieh; Yan, Guiyun; Fan, Qi; Xiao, Yuping; Cao, Yaming; Cui, Liwang.

In: American Journal of Tropical Medicine and Hygiene, Vol. 93, No. 3, 01.09.2015, p. 577-583.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria at the China-Myanmar Border

AU - Wang, Ying

AU - Yang, Zhaoqing

AU - Yuan, Lili

AU - Zhou, Guofa

AU - Parker, Daniel

AU - Lee, Ming Chieh

AU - Yan, Guiyun

AU - Fan, Qi

AU - Xiao, Yuping

AU - Cao, Yaming

AU - Cui, Liwang

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Artemisinin-based combination therapies (ACTs) are currently used as the first-line therapy for uncomplicated Plasmodium falciparum malaria. However, the recent emergence and/or spread of artemisinin resistance in parts of Greater Mekong Subregion (GMS) of southeast Asia requires close monitoring of the therapeutic efficacy of ACTs. This study was conducted from March 2012 to December 2013 in four clinics and seven villages along the China-Myanmar border. A total of 109 patients with uncomplicated falciparum malaria were treated with dihydroartemisinin-piperaquine (DP) and followed up on days 1, 2, 3, 7, 14, 21, 28, and 42 after treatment. A total of 71 patients (22 children and 49 adults) completed the 42-day follow-up. DP remained highly efficacious for treatment of uncomplicated falciparum malaria with an overall 42-day cure rate of 100%. The day 3 parasite-positive rate was 7.04% (5/71).Within 14 days of treatment, a total of 13 (18.31%) patients had detectable gametocytes and a large proportion of these were persistent from the first three days of treatment. The presence of gametocytes in patients through 14 days after DP treatment suggests that the incorporation of a single dose of primaquine for clearing gametocytemia should be considered for blocking parasite transmission.

AB - Artemisinin-based combination therapies (ACTs) are currently used as the first-line therapy for uncomplicated Plasmodium falciparum malaria. However, the recent emergence and/or spread of artemisinin resistance in parts of Greater Mekong Subregion (GMS) of southeast Asia requires close monitoring of the therapeutic efficacy of ACTs. This study was conducted from March 2012 to December 2013 in four clinics and seven villages along the China-Myanmar border. A total of 109 patients with uncomplicated falciparum malaria were treated with dihydroartemisinin-piperaquine (DP) and followed up on days 1, 2, 3, 7, 14, 21, 28, and 42 after treatment. A total of 71 patients (22 children and 49 adults) completed the 42-day follow-up. DP remained highly efficacious for treatment of uncomplicated falciparum malaria with an overall 42-day cure rate of 100%. The day 3 parasite-positive rate was 7.04% (5/71).Within 14 days of treatment, a total of 13 (18.31%) patients had detectable gametocytes and a large proportion of these were persistent from the first three days of treatment. The presence of gametocytes in patients through 14 days after DP treatment suggests that the incorporation of a single dose of primaquine for clearing gametocytemia should be considered for blocking parasite transmission.

UR - http://www.scopus.com/inward/record.url?scp=84941659528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941659528&partnerID=8YFLogxK

U2 - 10.4269/ajtmh.15-0029

DO - 10.4269/ajtmh.15-0029

M3 - Article

C2 - 26283743

AN - SCOPUS:84941659528

VL - 93

SP - 577

EP - 583

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 3

ER -